Adenocarcinoma & Metástasis ; Adenocarcinoma & Metastasis
Adenometástasis
Ana Belén
Fernández Martínez
Ana Belén Fernández Martínez-rekin lankidetzan egindako argitalpenak (10)
2015
-
VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells
Cellular Signalling, Vol. 27, Núm. 2, pp. 236-244
2014
-
Signalling pathways involved in antitumoral effects of VIP in human renal cell carcinoma A498 cells: VIP induction of p53 expression
International Journal of Biochemistry and Cell Biology, Vol. 53, pp. 295-301
2012
-
Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance
Histology and Histopathology, Vol. 27, Núm. 8, pp. 1093-1101
-
Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1823, Núm. 10, pp. 1676-1685
2010
-
Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer
Peptides, Vol. 31, Núm. 11, pp. 2035-2045
-
Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1
Cancer Letters, Vol. 299, Núm. 1, pp. 11-21
2009
-
Multifunctional role of VIP in prostate cancer progression in a xenograft model: Suppression by curcumin and COX-2 inhibitor NS-398
Peptides, Vol. 30, Núm. 12, pp. 2357-2364
-
Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells
Prostate, Vol. 69, Núm. 7, pp. 774-786
2007
-
Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-κB in human prostate cell lines. Differential time-dependent responses in cancer progression
Molecular and Cellular Endocrinology, Vol. 270, Núm. 1-2, pp. 8-16
2005
-
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog.
International journal of oncology, Vol. 26, Núm. 6, pp. 1629-1635